- About UCB US
- R & D
- Contact Us
Phase III trials involve a much larger group, usually between several hundred to several thousand patients, to help determine if the new drug can be considered both safe and effective in a larger population.
The goals of a Phase III trial are to:
Phase III trials may also be used to assess the efficacy and safety of the new drug when given in combination with other approved therapies.